New insights into TRAP1 pathway

American Journal of Cancer Research

Volumn 2, Issue 2, 2012, Pages 235-248

  Matassa, Danilo Swann ^a   Amoroso, Maria Rosaria ^a   Maddalena, Francesca ^b   Landriscina, Matteo ^c   Esposito, Franca ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS CROB Rionero in Vulture   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Apoptosis; Cancer; Drug resistance; Endoplasmic reticulum; HSP90; Mitochondria; Stress; TRAP1

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; GAMITRINIB; GEMCITABINE; HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR; IRINOTECAN; OXALIPLATIN; PREDNISONE; SHEPHERDIN; SORCIN; TANESPIMYCIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PROTEIN 1; UNCLASSIFIED DRUG; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CALCIUM HOMEOSTASIS; CANCER CELL; CELL PROTECTION; CELLULAR DISTRIBUTION; COLORECTAL CANCER; DNA DAMAGE; ENDOPLASMIC RETICULUM STRESS; GASTROINTESTINAL TOXICITY; HUMAN; LARGE CELL LYMPHOMA; LUNG NON SMALL CELL CANCER; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRION; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW;

EID: 84974798025     PISSN: None     EISSN: 21566976     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Song HY, Dunbar JD, Zhang YX, Guo D, Donner DB. Identification of a protein with homology to hsp90 that binds the type 1 tumor necrosis factor receptor. J Biol Chem 1995; 270: 3574-3581.
2. Chen CF, Chen Y, Dai K, Chen PL, Riley DJ, Lee WH. A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock. Mol Cell Biol 1996; 16: 4691-4699.
3. Felts SJ, Owen BA, Nguyen P, Trepel J, Donner DB, Toft DO. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties. J Biol Chem 2000; 275: 3305 -3312.
4. Cechetto JD, Gupta RS. Immunoelectron microscopy provides evidence that tumor necrosis factor receptor-associated protein 1 (TRAP-1) is a mitochondrial protein which also localizes at specific extramitochondrial sites. Exp Cell Res 2000; 260: 30-39.
5. Kang BH, Plescia J, Dohi T, Rosa J, Doxsey SJ, Altieri DC. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 2007; 131: 257-270.
6. Leskovar A, Wegele H, Werbeck ND, Buchner J, Reinstein J. The ATPase cycle of the mitochondrial hsp90 analog Trap1. J Biol Chem 2008; 283: 11677-11688.
7. Ban C, Junop M, and Yang W. Transformation of MutL by ATP binding and hydrolysis: a switch in DNA mismatch repair. Cell 1999; 97: 85-97.
8. Amoroso MR, Matassa DS, Laudiero G, Egorova AV, Polishchuk RS, Maddalena F, Piscazzi A, Paladino S, Sarnataro D, Garbi C, Landriscina M, Esposito F. TRAP1 and the proteasome regulatory particle TBP7/Rpt3 interact in the endoplasmic reticulum and control cellular ubiquitination of specific mitochondrial proteins. Cell Death Differ 2011; doi: 10.1038/cdd.2011.128. [Epub ahead of print]
9. Kirkin V, Dikic I. Ubiquitin networks in cancer. Curr Opin Genet Dev 2011; 21: 21-28.
10. Meyers MB, Pickel VM, Sheu SS, Sharma VK, Scotto KW, Fishman GI. Association of Sorcin with the cardiac ryanodine receptor. J Biol Chem 1995; 270: 26411-26418.
11. Farrell EF, Antaramian A, Rueda A, Gómez AM, Valdivia HH. Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. J Biol Chem 2003; 278: 34660-34666.
12. Meyers MB, Fischer A, Sun YJ, Lopes CM, Rohacs T, Nakamura TY, Zhou YY, Lee PC, Altschuld RA, McCune SA, Coetzee WA, Fishman GI. Sorcin regulates excitation-contraction coupling in the heart. J Biol Chem 2003; 278: 28865-28871.
13. Meyers MB, Puri TS, Chien AJ, Gao T, Hsu PH, Hosey MM, Fishman GI. Sorcin associates with the pore-forming subunit of voltage dependent L-type Ca2+ channels. J Biol Chem 1998; 273: 18930-18935.
14. Zamparelli C, Macquaide N, Colotti G, Verzili D, Seidler T, Smith GL, Chiancone E. Activation of the cardiac Na(+)-Ca(2+) exchanger by sorcin via the interaction of the respective Ca(2+)-binding domains. J Mol Cell Cardiol 2010; 49: 132-141.
15. Wang SL, Tam MF, Ho YS, Pai SH, Kao MC. Isolation and molecular cloning of human sorcin a calcium-binding protein in vincristineresistant HOB1 lymphoma cells. Biochim Biophys Acta 1995; 1260: 285-293.
16. Yang YX, Chen ZC, Zhang GY, Yi H, Xiao ZQ. A subcellular proteomic investigation into vincristine-resistant gastric cancer cell line. J Cell Biochem 2008; 104: 1010-1021.
17. Qu Y, Yang Y, Liu B, Xiao W. Comparative proteomic profiling identified Sorcin being associated with gemcitabine resistance in non-small cell lung cancer. Med Oncol 2010; 27: 1303-1308.
18. Maxwell SA, Cherry EM, Bayless KJ. Akt, 14-3-3ζ, and vimentin mediate a drug-resistant invasive phenotype in diffuse large B-cell lymphoma. Leuk Lymphoma 2011; 52: 849-864.
19. Kawakami M, Nakamura T, Okamura N, Komoto C, Markova S, Kobayashi H, Hashimoto N, Okumura K, Sakaeda T. Knock-down of Sorcin induces up-regulation of MDR1 in HeLa cells. Biol Pharm Bull 2007; 30: 1065-1073.
20. Zhou Y, Xu Y, Tan Y, Qi J, Xiao Y, Yang C, Zhu Z, Xiong D. Sorcin, an important gene associated with multidrug-resistance in human leukemia cells. Leuk Res 2006; 30: 469-476.
21. He Q, Zhang G, Hou D, Leng A, Xu M, Peng J, Liu T. Overexpression of sorcin results in multidrug resistance in gastric cancer cells with upregulation of P-gp. Oncol Rep 2011; 25: 237-243.
22. Nagpal JK, Das BR. Identification of differentially expressed chewing-mediated oral cancer by differential display-polymerase chain reaction. Eur J Clin Invest 2007; 37: 658-664.
23. Tan Y, Li G, Zhao C, Wang J, Zhao H, Xue Y, Han M, Yang C. Expression of sorcin predicts poor outcome in acute myeloid leukemia. Leuk Res 2003; 27: 125-131.
24. Landriscina M, Laudiero G, Maddalena F, Amoroso MR, Piscazzi A, Cozzolino F, Monti M, Garbi C, Fersini A, Pucci P, Esposito F. Mitochondrial chaperone Trap1 and the calcium binding protein Sorcin interact and protect cells against apoptosis induced by antiblastic agents. Cancer Res 2010; 70: 6577-6586.
25. Maddalena F, Laudiero G, Piscazzi A, Secondo A, Scorziello A, Lombardi V, Matassa DS, Fersini A, Neri V, Esposito F, Landriscina M. Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca2+ homeostasis. Cancer Res 2011; 71: 7659-7669.
26. Mattson MP. Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid Redox Signal 2006; 8: 1997-2006.
27. Sulová Z, Seres M, Barancík M, Gibalová L, Uhrík B, Poleková L, Breier A. Does any relationship exist between P-glycoprotein-mediated multidrug resistance and intracellular calcium homeostasis. Gen Physiol Biophys 2009; 28: F89-95.
28. Takemoto K, Miyata S, Takamura H, Katayama T, Tohyama M. Mitochondrial TRAP1 regulates the unfolded protein response in the endoplasmic reticulum. Neurochem Int 2011; 58: 880-887.
29. Siegelin MD, Dohi T, Raskett CM, Orlowski GM, Powers CM, Gilbert CA, Ross AH, Plescia J, Altieri DC. Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest 2011; 121: 1349-1360.
30. Montesano Gesualdi N, Chirico G, Pirozzi G, Costantino E, Landriscina M, Esposito F. Tumor necrosis factor-associated protein 1 (TRAP-1) protects cells from oxidative stress and apoptosis. Stress 2007; 10: 342-350.
31. Im CN, Lee JS, Zheng Y, Seo JS. Iron chelation study in a normal human hepatocyte cell line suggests that tumor necrosis factor receptorassociated protein 1 (TRAP1) regulates production of reactive oxygen species. J Cell Biochem 2007; 100: 474-486.
32. Hua G, Zhang Q, Fan Z. Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme Mmediated apoptosis. J Biol Chem 2007; 282: 20553-20560.
33. Pridgeon JW, Olzmann JA, Chin LS, Li L. PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1. PLoS Biol 2007; 5: e172.
34. Chien WL, Lee TR, Hung SY, Kang KH, Lee MJ, Fu WM. Impairment of oxidative stress-induced heme oxygenase-1 expression by the defect of Parkinson-related gene of PINK1. J Neurochem 2011; 117: 643-653.
35. Xu L, Voloboueva LA, Ouyang Y, Emery JF and Giffard RG. Overexpression of mitochondrial Hsp70/Hsp75 in rat brain protects mitochondria, reduces oxidative stress, and protects from focal ischemia. J Cereb Blood Flow Metab 2009; 29: 365-374.
36. Ghosh JC, Siegelin MD, Dohi T, Altieri DC. Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res 2010; 70: 8988-8993.
37. Altieri DC, Stein GS, Lian JB, Languino LR. TRAP -1, the mitochondrial Hsp90. Biochim Biophys Acta. 2011 Aug 22. [Epub ahead of print]
38. Kang BH, Altieri DC. Compartmentalized cancer drug discovery targeting mitochondrial Hsp90 chaperones. Oncogene 2009; 28: 3681-3688.
39. Xiang F, Huang YS, Shi XH, Zhang Q. Mitochondrial chaperone tumour necrosis factor receptor-associated protein 1 protects cardiomyocytes from hypoxic injury by regulating mitochondrial permeability transition pore opening. FEBS J 2010; 277: 1929-1938.
40. Kubota K, Inoue K, Hashimoto R, Kumamoto N, Kosuga A, Tatsumi M, Kamijima K, Kunugi H, Iwata N, Ozaki N, Takeda M, Tohyama M. Tumor necrosis factor receptor-associated protein 1 regulates cell adhesion and synaptic morphology via modulation of N-cadherin expression. J Neurochem 2009; 110: 496-508.
41. Nguyen MC, Tu GH, Koprivnikar KE, Gonzalez-Edick M, Jooss KU, Harding TC. Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSFsecreting cellular immunotherapy. Cancer Immunol Immunother 2010; 59: 1313-1323.
42. Liu D, Hu J, Agorreta J, Cesario A, Zhang Y, Harris AL, Gatter K, Pezzella F. Tumor necrosis factor receptor-associated protein 1 (TRAP1) regulates genes involved in cell cycle and metastases. Cancer Lett 2010; 296: 194-205.
43. Leav I, Plescia J, Goel HL, Li J, Jiang Z, Cohen RJ, Languino LR, Altieri DC. Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. Am J Pathol 2010; 176: 393-401.
44. Russo A, Cirulli C, Amoresano A, Pucci P, Pietropaolo C, Russo G. Cis-acting sequences and trans-acting factors in the localization of mRNA for mitochondrial ribosomal proteins. BBA 2008; 1779: 820-829.
45. Yamamoto K, Okamoto A, Isonishi S, Ochiai K, Ohtake Y. Heat shock protein 27 was upregulated in cisplatin resistant human ovarian tumor cell line and associated with the cisplatin resistance. Cancer Lett 2001; 168: 173-181.
46. Macleod K, Mullen P, Sewell J, Rabiasz G, Lawrie S, Miller E, Smyth JF, Langdon SP. Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer. Cancer Res 2005; 65: 6789-6800.
47. Landriscina M, Amoroso MR, Piscazzi A, Esposito F. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy. Gynecol Oncol 2010; 117: 177-182.
48. Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S, Xie S, Liu Q, Liu T, Huang J, Xie W, Li Z, Zhao Y, Wang E, Marincola FM, Yao K. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med 2008; 20: 6-32.
49. Costantino E, Maddalena F, Calise S, Piscazzi A, Tirino V, Fersini A, Ambrosi A, Neri V, Esposito F, Landriscina M. TRAP1, a novel mitochondrial chaperone responsible for multi-drug resistance and protection from apoptotis in human colorectal carcinoma cells. Cancer Lett 2009; 279: 39-46.
50. Usmani SZ, Bona R, Li Z. 17 AAG for HSP90 inhibition in cancer--from bench to bedside. Curr Mol Med 2009; 9: 654-664.
51. Plescia J, Salz W, Xia F, Pennati M, Zaffaroni N, Daidone MG, Meli M, Dohi T, Fortugno P, Nefedova Y, Gabrilovich DI, Colombo G, Altieri DC. Rational design of shepherdin, a novel anticancer agent. Cancer Cell 2005; 7: 457-468.
52. Altieri DC. Mitochondrial compartmentalized protein folding and tumor cell survival. Oncotarget 2011; 2: 347-351.
53. Kang BH, Plescia J, Song HY, Meli M, Colombo G, Beebe K, Scroggins B, Neckers L, Altieri DC. Combinatorial drug design targetingmultiple cancer signaling networks controlled by mito chondrial Hsp90. J Clin Invest 2009; 119: 454-464.
54. Taipale M, Jarosz DF, Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 2010; 11: 515-528.
55. Patterson C, Ronnebaum S. Breast cancer quality control. Nat Cell Biol 2009; 11: 239-241.
56. Kajiro M, Hirota R, Nakajima Y, Kawanowa K, Kimura K and Yanagisawa J. The ubiquitin ligase CHIP acts as an upstream regulator of oncogenic pathways Nature Cell Biology 2009; 11: 312-319.